The Curious Case of a Catatonic Patient
| Autor: | John H. Enterman, Dyllis van Dijk |
|---|---|
| Rok vydání: | 2010 |
| Předmět: |
Adult
Male medicine.medical_specialty Pediatrics Catatonia medicine.medical_treatment Lorazepam Drug Administration Schedule Diagnosis Differential Electroconvulsive therapy Pharmacotherapy Anti-Anxiety Agents Recurrence medicine Humans Electroconvulsive Therapy Psychiatry Depression (differential diagnoses) Schizophrenia Paranoid Dose-Response Relationship Drug Schizophrenia Catatonic Special Features medicine.disease Combined Modality Therapy Flupenthixol Psychiatry and Mental health Schizophrenia Delayed-Action Preparations Drug Therapy Combination medicine.symptom Psychology Mania Antipsychotic Agents Follow-Up Studies medicine.drug |
| Zdroj: | Schizophrenia Bulletin. 37:235-237 |
| ISSN: | 1745-1701 0586-7614 |
| Popis: | Catatonia is a syndrome characterized by the coexistence of psychiatric and motor symptoms.1 It is associated with a wide range of psychiatric, medical, neurological, and drug-induced disorders.2 The concept of catatonia was first described by the German psychiatrist Kahlbaum in 1874.3 It is more frequently found among patients diagnosed with mania, depression, and neurotoxic syndromes than among those with schizophrenia. Yet, it is mainly classified as a form of schizophrenia.4 The exact cause of catatonia has not been elucidated. The syndrome of catatonia is defined by the objective presence of motor signs, over 40 of which have been described. These catatonic signs are listed in table 1. There is no agreed threshold for the number or duration of symptoms that should be present to justify a diagnosis of catatonia. Research has suffered from this, and studies can rarely be compared with confidence.7 Table 1. Principal Features of Catatonia5,6 There are consistent clinical reports that benzodiazepines are effective in acute catatonia syndromes, particularly stuporous conditions, but no placebo-controlled randomized studies have been published.8,9 However, benzodiazepines are the drugs of choice for catatonia.10 In most cases, lorazepam is administered parenterally or orally beginning with 3 mg/d and increasing rapidly to effective resolution. Dosages of 20–30 mg/d are occasionally necessary.5 Patients who are unresponsive or insufficiently responsive to benzodiazepines need electroconvulsive therapy (ECT).5,10 |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|